Back to GetFilings.com



Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 10-Q
 
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2002
 
or
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the period from                      to                         
 
Commission file number 0-5404
 

 
ANALEX CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of
incorporation or organization)
 
71-0869563
(I.R.S. Employer
Identification No.)
 
5904 Richmond Highway
Suite 300
Alexandria, Virginia 22303
(Address of principal executive offices)
 
Registrant’s Telephone number including area code
(703) 329-9400
 

 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:  Yes  x  No  ¨
 
As of November 7, 2002, 14,442,702 shares of the Common Stock of the registrant were outstanding.
 


Table of Contents
 
ANALEX CORPORATION
 
TABLE OF CONTENTS
 
Part I    Financial Information:
    
Page No.

Item 1.
  
Financial Statements
      
         
3
         
5
         
6
         
7
Item 2.
       
15
Item 3.
       
19
Item 4.
       
20
Part II    Other Information:
      
Item 1.
       
21
Item 6.
       
21
    
22


Table of Contents
ANALEX CORPORATION
 
CONSOLIDATED BALANCE SHEETS
September 30, 2002 and December 31, 2001
    
September 30,
2002

  
December 31,
2001

ASSETS
             
Current assets:
             
Cash and cash equivalents
  
$
455,400
  
$
83,100
Accounts receivable, net
  
 
11,325,000
  
 
8,377,600
Prepaid expenses and other
  
 
182,100
  
 
223,300
    

  

Total current assets
  
 
11,962,500
  
 
8,684,000
    

  

Fixed assets, net
  
 
373,000
  
 
260,600
Goodwill
  
 
14,821,200
  
 
15,638,100
Other Intangibles
  
 
654,100
  
 
850,500
Contract Rights
  
 
964,300
  
 
—  
Deferred finance costs
  
 
167,200
  
 
72,500
Other
  
 
61,900
  
 
119,400
    

  

Total other assets
  
 
17,041,700
  
 
16,941,100
    

  

Total assets
  
$
29,004,200
  
$
25,625,100
    

  

 
See Notes to Consolidated Financial Statements

3


Table of Contents
 
ANALEX CORPORATION
 
CONSOLIDATED BALANCE SHEETS
September 30, 2002 and December 31, 2001
 
    
September 30,
    
December 31,
 
    
2002

    
2001

 
LIABILITIES AND SHAREHOLDERS' EQUITY
                 
Current liabilities:
                 
Accounts payable
  
$
1,825,900
 
  
$
1,371,400
 
Note payable—line of credit
  
 
1,704,800
 
  
 
1,696,500
 
Note payable—bank term note
  
 
700,000
 
  
 
700,000
 
Notes payable—other
  
 
813,800
 
  
 
838,500
 
Other current liabilities
  
 
6,030,100
 
  
 
4,779,400
 
    


  


Total current liabilities
  
 
11,074,600
 
  
 
9,385,800
 
    


  


Note payable—bank term note
  
 
2,230,300
 
  
 
2,741,600
 
Notes payable—other
  
 
2,661,400
 
  
 
2,262,600
 
Other
  
 
—  
 
  
 
60,000
 
    


  


Total long-term liabilities
  
 
4,891,700
 
  
 
5,064,200
 
    


  


Commitments and contingencies
                 
Total liabilities
  
 
15,966,300
 
  
 
14,450,000
 
    


  


Shareholders’ equity:
                 
Common stock $.02 par; authorized 30,000,000 shares;
                 
issued and outstanding—September 30, 2002 14,442,702 shares
                 
and December 31, 2001, 14,375,975 shares
  
 
288,900
 
  
 
287,500
 
Additional capital
  
 
21,160,800
 
  
 
20,726,300
 
Deferred compensation
  
 
(16,200
)
  
 
(22,300
)
Accumulated other comprehensive loss
  
 
(92,700
)
  
 
—  
 
Accumulated deficit
  
 
(8,302,900
)
  
 
(9,816,400
)
    


  


Total shareholders’ equity
  
 
13,037,900
 
  
 
11,175,100
 
    


  


Total liabilities and shareholders’ equity
  
$
29,004,200
 
  
$
25,625,100
 
    


  


 
See Notes to Consolidated Financial Statements
 

4


Table of Contents
 
ANALEX CORPORATION
 
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three and Nine Months Ended September 30, 2002 and 2001
 
    
Three Months Ended
September 30,

    
Nine Months Ended
September 30,

 
    
2002

    
2001

    
2002

    
2001

 
Revenues
  
$
16,318,600
 
  
$
4,137,300
 
  
$
42,282,300
 
  
$
12,724,800
 
Operating costs and expenses:
                                   
Costs of revenue
  
 
13,800,100
 
  
 
3,329,100
 
  
 
36,060,100
 
  
 
10,338,300
 
Selling, general and administrative
  
 
1,194,100
 
  
 
600,000
 
  
 
3,591,400
 
  
 
1,847,500
 
Amortization of goodwill and other intangibles
  
 
92,200
 
  
 
84,000
 
  
 
232,200
 
  
 
252,000
 
    


  


  


  


Total operating costs and expenses
  
 
15,086,400
 
  
 
4,013,100
 
  
 
39,883,700
 
  
 
12,437,800
 
    


  


  


  


Operating income
  
 
1,232,200
 
  
 
124,200
 
  
 
2,398,600
 
  
 
287,000
 
    


  


  


  


Other income (expense):
                                   
Interest income
  
 
600
 
  
 
—  
 
  
 
1,200
 
  
 
—  
 
Interest expense
  
 
(269,700
)
  
 
(25,200
)
  
 
(780,100
)
  
 
(97,200
)
Other expense
  
 
(38,900
)
  
 
(44,900
)
  
 
(82,200
)
  
 
(42,000
)
    


  


  


  


Total other expense
  
 
(308,000
)
  
 
(70,100
)
  
 
(861,100
)
  
 
(139,200
)
    


  


  


  


Income before income taxes
  
 
924,200
 
  
 
54,100
 
  
 
1,537,500
 
  
 
147,800
 
Provision for income taxes
  
 
10,200
 
  
 
—  
 
  
 
23,900
 
  
 
—  
 
    


  


  


  


Net income
  
$
914,000
 
  
$
54,100
 
  
$
1,513,600
 
  
$
147,800
 
    


  


  


  


Net income per share:
                                   
Basic
  
$
0.06
 
  
$
0.01
 
  
$
0.11
 
  
$
0.02
 
    


  


  


  


Diluted
  
$
0.05
 
  
$
0.01
 
  
$
0.09
 
  
$
0.02
 
    


  


  


  


Weighted average number of shares:
                                   
Basic
  
 
14,238,707
 
  
 
6,536,276
 
  
 
14,408,181
 
  
 
6,520,040
 
    


  


  


  


Diluted
  
 
17,013,845
 
  
 
8,186,996
 
  
 
16,981,384
 
  
 
7,971,382
 
    


  


  


  


 
See Notes to Consolidated Financial Statements

5


Table of Contents
 
ANALEX CORPORATION
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2002 and 2001
 
 
    
September 30,

 
    
2002

    
2001

 
Cash flows from operating activities:
                 
Net income
  
$
1,513,600
 
  
$
147,800
 
    


  


Adjustments to reconcile net income to net
                 
cash provided by operating activities:
                 
Depreciation
  
 
73,700
 
  
 
100,500
 
Amortization of goodwill
  
 
—  
 
  
 
252,000
 
Amortization of intangibles
  
 
232,200
 
  
 
—  
 
Non-cash interest expense
  
 
270,700
 
  
 
—  
 
Stock compensation expense
  
 
6,100
 
  
 
4,000
 
Changes in operating assets and liabilities:
                 
Accounts receivable
  
 
(2,947,400
)
  
 
356,300
 
Prepaid expenses and other
  
 
41,200
 
  
 
(309,700
)
Other assets
  
 
57,500
 
  
 
(17,300
)
Accounts payable<